Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124249443 | 12424944 | 3 | F | 201403 | 20160719 | 20160601 | 20160720 | EXP | US-BAYER-2016-048962 | BAYER | 53.00 | YR | A | M | Y | 0.00000 | 20160720 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124249443 | 12424944 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 15 MG, UNK | Y | UNKNOWN;UNKNOWN | 0 | 15 | MG | FILM-COATED TABLET | |||||
| 124249443 | 12424944 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 15 MG, UNK | Y | UNKNOWN;UNKNOWN | 0 | 15 | MG | FILM-COATED TABLET | |||||
| 124249443 | 12424944 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 15 MG, UNK | Y | UNKNOWN;UNKNOWN | 0 | 15 | MG | FILM-COATED TABLET | |||||
| 124249443 | 12424944 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, UNK | Y | UNKNOWN;UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | |||||
| 124249443 | 12424944 | 5 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, UNK | Y | UNKNOWN;UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | |||||
| 124249443 | 12424944 | 6 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, UNK | Y | UNKNOWN;UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | |||||
| 124249443 | 12424944 | 7 | PS | ACETYLSALICYLIC ACID (} 100 MG, FAST RELEASE) | ASPIRIN | 1 | Oral | 325 MG, UNK | Y | 999999 | 325 | MG | MODIFIED-RELEASE TABLET | ||||||
| 124249443 | 12424944 | 8 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, UNK | Y | 0 | 75 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124249443 | 12424944 | 1 | Thrombosis prophylaxis |
| 124249443 | 12424944 | 2 | Thrombosis prophylaxis |
| 124249443 | 12424944 | 3 | Thrombosis prophylaxis |
| 124249443 | 12424944 | 4 | Thrombosis prophylaxis |
| 124249443 | 12424944 | 5 | Thrombosis prophylaxis |
| 124249443 | 12424944 | 6 | Thrombosis prophylaxis |
| 124249443 | 12424944 | 7 | Deep vein thrombosis |
| 124249443 | 12424944 | 8 | Deep vein thrombosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124249443 | 12424944 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124249443 | 12424944 | Dieulafoy's vascular malformation | |
| 124249443 | 12424944 | Haematoma | |
| 124249443 | 12424944 | Haemorrhagic arteriovenous malformation | |
| 124249443 | 12424944 | Swelling | |
| 124249443 | 12424944 | Upper gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124249443 | 12424944 | 1 | 20140212 | 201403 | 0 | |
| 124249443 | 12424944 | 2 | 20140414 | 201404 | 0 | |
| 124249443 | 12424944 | 3 | 2014 | 201405 | 0 | |
| 124249443 | 12424944 | 4 | 20140513 | 201412 | 0 | |
| 124249443 | 12424944 | 5 | 20141217 | 201511 | 0 | |
| 124249443 | 12424944 | 6 | 20151119 | 0 | ||
| 124249443 | 12424944 | 7 | 20140212 | 201404 | 0 | |
| 124249443 | 12424944 | 8 | 20140212 | 201404 | 0 |